← Back to Patent Explorer
US3928326A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the separation of stereoisomeric mixtures into their components and components obtained hereby

Assignee: Saab Bofors AB
•
Filing: 1973-05-14
•
Granted: 1975-12-23
•
Expires: 1993-05-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for the resolution of stereoisomeric mixtures of certain steroids obtained by synthesis into its components, comprising subjecting the stereoisomeric mixture to gel filtration, the components in view of different retention volumes being separated and being separately recoverable; and stereoisomeric components A and B thereby obtained, pharmaceutical compositions thereof; and method of treating inflammation therewith.

Inventors

  • 👤 Ralph Lennart Brattsand
  • 👤 Bo Thuresson Af Ekenstam
  • 👤 Karl Goran Claeson
  • 👤 Bror Arne Thalen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 22:35
CPC Classifications
C; C07; C07J; C07J71/00; C07J71/0005; C07J71/0026; C07J71/0031; A; A61; A61K; A61K31/00; A61K31/56; A61K31/57; A61P; A61P29/00

Claims Analysis

Total Claims: 25
Claim 1
Independent Claim 16 words
A process for the resolution of stereoisomeric mixtures (isomer pairs) of steroids having the general formula:
Claim 2
Dependent Claim 16 words
A process for the resolution of stereoisomeric mixtures (isomer pairs) of steroids having the general formula:
Claim 3
Dependent Claim 18 words
A process according to claim 1, characterized by carrying out the gel filtration on a cross-linked dextran gel.
Claim 4
Dependent Claim 17 words
A process according to claim 2, characterized in carrying out the gel filtration on Sephadex LH 20.
Claim 5
Dependent Claim 19 words
A process according to claim 1, characterized by carrying out the gel filtration on a copolymer of vinyl acetate.
Claim 6
Dependent Claim 16 words
A process according to claim 4, characterized by carrying out the gel filtration on Merckogel OR-PVA.
Claim 7
Dependent Claim 28 words
A process according to any of claim 1, characterized by carrying out the gel filtration by means of an eluating agent selected from halogenated hydrocarbons, ethers and esters.
Claim 8
Dependent Claim 26 words
A process according to claim 6, characterized by carrying out the gel filtration with an eluating agent selected from ethyl acetate, acetonitrile, methylene chloride and chloroform.
Claim 9
Dependent Claim 16 words
STEROISMERIC COMPONENT B OF A STEROISOMERIC MIXTURE ISOMERIC PAIR) OF A STEROID HAVING THE GENERAL FORMULA:
Claim 10
Dependent Claim 16 words
STEROISMERIC COMPONENT B OF A STEROISOMERIC MIXTURE ISOMERIC PAIR) OF A STEROID HAVING THE GENERAL FORMULA:
Claim 11
Dependent Claim 18 words
Stereoisomeric component according to claim 8 characterized in that R is an alkyl group having 1-6 carbon atoms.
Claim 12
Dependent Claim 37 words
Stereoisomeric component according to claim 9, wherein Z is hydroxyl esterified with an acid selected from acetic acid, propionic acid, butyric acid, valeric acid, isovaleric acid, trimethyl acetic acid, hexanoic acid, tert. butylacetic acid and octanoic acid.
Claim 13
Dependent Claim 23 words
Stereoisomeric component according to clAim 9, wherein Z is hydroxyl esterified with an acid selected from pyridine-3-, pyridine-4-, benzofurane-2-carboxylic acid and methoxymethylcarboxylic acids.
Claim 14
Dependent Claim 25 words
Stereoisomeric component according to claim 9, wherein Z is hydroxyl esterified with an acid selected from dicarboxylic acids, preferably such acids having 2-12 carbon atoms.
Claim 15
Dependent Claim 20 words
Stereoisomeric component according to claim 9, wherein Z is hydroxyl esterified with an acid selected from phosphoric and sulphuric acids.
Claim 16
Dependent Claim 16 words
Stereoisomeric component B according to claim 8, which is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-methyl)methylenedioxy-9-fluoropregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 17
Dependent Claim 16 words
Stereoisomeric component B according to claim 8, which is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-n-propyl)methylenedioxy-9-fluoropregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 18
Dependent Claim 18 words
Stereoisomeric component B according to claim 8, which is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-methyl)methylenedioxy-6 Alpha ,9-difluoropregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 19
Dependent Claim 18 words
Stereoisomeric component B according to claim 8, which is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-n-propyl)methylenedioxy-6 Alpha ,9-difluoropregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 20
Dependent Claim 16 words
Stereoisomeric component B according to claim 8, which is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-n-propyl)methylenedioxypregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 21
Dependent Claim 17 words
A process according to claim 1, wherein the steroid is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-methyl)methylenedioxy-9-fluoropregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 22
Dependent Claim 17 words
A process according to claim 1, wherein the steroid is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-n-propyl)methylenedioxy-9-fluoropregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 23
Dependent Claim 20 words
A process according to claim 1, wherein the steroid is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-methyl)methylenedioxy-6 Alpha , 9-difluoropregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 24
Dependent Claim 19 words
A process according to claim 1, wherein the steroid is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-n-propyl)methylenedioxy-6 Alpha ,9-difluoropregna-1,4-diene-11 Beta ,21-diol-3,20-dione.
Claim 25
Dependent Claim 18 words
A process according to claim 1, wherein the steroid is 16 Alpha ,17 Alpha -(2''-hydrogen-2''-n-propyl)methylenedioxypregna-1, 4-diene-11 Beta ,21-diol-3,20-dione.

References Cited (Backward Citations)

US3133940A Cited
US3048581A Cited
US3128238A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-12-22 1979-06-23 1979-12-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-12-22 1983-06-23 1983-12-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-12-22 1987-06-23 1987-12-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag